139 related articles for article (PubMed ID: 7675940)
1. Oral administration of NNC 756--a placebo controlled PET study of D1-dopamine receptor occupancy and pharmacodynamics in man.
Karlsson P; Farde L; Halldin C; Sedvall G; Ynddal L; Sloth-Nielsen M
Psychopharmacology (Berl); 1995 May; 119(1):1-8. PubMed ID: 7675940
[TBL] [Abstract][Full Text] [Related]
2. 11C- and 76Br-labelled NNC 22-0010, selective dopamine D1 receptor radioligands for PET.
Foged C; Halldin C; Loc'h C; Mazière B; Karlsson P; Mazière M; Swahn CG; Farde L
Nucl Med Biol; 1996 Aug; 23(6):837-44. PubMed ID: 8940728
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of SCH 39166 as PET ligand for central D1 dopamine receptor binding and occupancy in man.
Karlsson P; Sedvall G; Halldin C; Swahn CG; Farde L
Psychopharmacology (Berl); 1995 Oct; 121(3):300-8. PubMed ID: 8584610
[TBL] [Abstract][Full Text] [Related]
4. [11C]NNC 22-0215, a metabolically stable dopamine D1 radioligand for PET.
Foged C; Halldin C; Swahn CG; Ginovart N; Karlsson P; Lundkvist C; Farde L
Nucl Med Biol; 1998 Jul; 25(5):503-8. PubMed ID: 9720669
[TBL] [Abstract][Full Text] [Related]
5. PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor.
Karlsson P; Farde L; Halldin C; Swahn CG; Sedvall G; Foged C; Hansen KT; Skrumsager B
Psychopharmacology (Berl); 1993; 113(2):149-56. PubMed ID: 7855175
[TBL] [Abstract][Full Text] [Related]
6. Dopamine receptor occupancy in vivo: behavioral correlates using NNC-112, NNC-687 and NNC-756, new selective dopamine D1 receptor antagonists.
Nielsen EB; Andersen PH
Eur J Pharmacol; 1992 Aug; 219(1):35-44. PubMed ID: 1397048
[TBL] [Abstract][Full Text] [Related]
7. Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors.
Halldin C; Foged C; Chou YH; Karlsson P; Swahn CG; Sandell J; Sedvall G; Farde L
J Nucl Med; 1998 Dec; 39(12):2061-8. PubMed ID: 9867142
[TBL] [Abstract][Full Text] [Related]
8. [11C]NNC 687 and [11C]NNC 756, dopamine D-1 receptor ligands. Preparation, autoradiography and PET investigation in monkey.
Halldin C; Foged C; Farde L; Karlsson P; Hansen K; Grønvald F; Swahn CG; Hall H; Sedvall G
Nucl Med Biol; 1993 Nov; 20(8):945-53. PubMed ID: 8298574
[TBL] [Abstract][Full Text] [Related]
9. NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists.
Andersen PH; Grønvald FC; Hohlweg R; Hansen LB; Guddal E; Braestrup C; Nielsen EB
Eur J Pharmacol; 1992 Aug; 219(1):45-52. PubMed ID: 1397049
[TBL] [Abstract][Full Text] [Related]
10. PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756.
Abi-Dargham A; Simpson N; Kegeles L; Parsey R; Hwang DR; Anjilvel S; Zea-Ponce Y; Lombardo I; Van Heertum R; Mann JJ; Foged C; Halldin C; Laruelle M
Synapse; 1999 May; 32(2):93-109. PubMed ID: 10231129
[TBL] [Abstract][Full Text] [Related]
11. PET studies on dopamine D1 receptors in the human brain with carbon-11-SCH 39166 and carbon-11-NNC 756.
Laihinen AO; Rinne JO; Ruottinen HM; Någren KA; Lehikoinen PK; Oikonen VJ; Ruotsalainen UH; Rinne UK
J Nucl Med; 1994 Dec; 35(12):1916-20. PubMed ID: 7989969
[TBL] [Abstract][Full Text] [Related]
12. Clozapine binds preferentially to cortical D1-like dopamine receptors in the primate brain: a PET study.
Chou YH; Halldin C; Farde L
Psychopharmacology (Berl); 2006 Mar; 185(1):29-35. PubMed ID: 16395606
[TBL] [Abstract][Full Text] [Related]
13. Tolerability, safety and pharmacokinetics of single dose and multiple dosing of the selective D1 antagonist NNC 01-0687 in healthy subjects.
Skrumsager BK; Christensen JV; Snel S; Seiberling M
Psychopharmacology (Berl); 1995 Oct; 121(3):294-9. PubMed ID: 8584609
[TBL] [Abstract][Full Text] [Related]
14. [11C]NNC 112 selectivity for dopamine D1 and serotonin 5-HT(2A) receptors: a PET study in healthy human subjects.
Slifstein M; Kegeles LS; Gonzales R; Frankle WG; Xu X; Laruelle M; Abi-Dargham A
J Cereb Blood Flow Metab; 2007 Oct; 27(10):1733-41. PubMed ID: 17311076
[TBL] [Abstract][Full Text] [Related]
15. Selective alterations of the first NREM sleep cycle in humans by a dopamine D1 receptor antagonist (NNC-687).
Eder DN; Zdravkovic M; Wildschiødtz G
J Psychiatr Res; 2003; 37(4):305-12. PubMed ID: 12765853
[TBL] [Abstract][Full Text] [Related]
16. Selective D1- and D2-dopamine receptor blockade both induces akathisia in humans--a PET study with [11C]SCH 23390 and [11C]raclopride.
Farde L
Psychopharmacology (Berl); 1992; 107(1):23-9. PubMed ID: 1534178
[TBL] [Abstract][Full Text] [Related]
17. Lack of effect of the dopamine D1 antagonist, NNC 01-0687, on unstimulated and stimulated release of anterior pituitary hormones in males.
Grodum E; Andersen M; Hangaard J; Koldkjaer O; Hagen C
J Endocrinol Invest; 1998 May; 21(5):291-7. PubMed ID: 9648050
[TBL] [Abstract][Full Text] [Related]
18. Long-term treatment with low doses of the D1 antagonist NNC 756 and the D2 antagonist raclopride in monkeys previously exposed to dopamine antagonists.
Lublin H; Gerlach J; Mørkeberg F
Psychopharmacology (Berl); 1994 Apr; 114(3):495-504. PubMed ID: 7855208
[TBL] [Abstract][Full Text] [Related]
19. The dopamine D₁ receptor agonist (S)-[¹¹C]N-methyl-NNC 01-0259 is not sensitive to changes in dopamine concentration--a positron emission tomography examination in the monkey brain.
Finnema SJ; Bang-Andersen B; Jørgensen M; Christoffersen CT; Gulyás B; Wikström HV; Farde L; Halldin C
Synapse; 2013 Sep; 67(9):586-95. PubMed ID: 23504964
[TBL] [Abstract][Full Text] [Related]
20. Dopamine depletion and in vivo binding of PET D1 receptor radioligands: implications for imaging studies in schizophrenia.
Guo N; Hwang DR; Lo ES; Huang YY; Laruelle M; Abi-Dargham A
Neuropsychopharmacology; 2003 Sep; 28(9):1703-11. PubMed ID: 12813475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
